Close Menu

NEW YORK (GenomeWeb) – Prescient Medicine Holdings said today that it has acquired privately held molecular diagnostics firm AutoGenomics for an undisclosed amount.

AutoGenomics, based on Carlsbad, California, has developed and commercialized the Infiniti platform, a US Food and Drug Administration 510(k)-exempt automated microarray-based diagnostic system with applications in personalized medicine, pain management, cardiovascular health, mental health, women's health, oncology, infectious diseases, and genetic disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.